Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Abbott Laboratories Q1 2024 Adj EPS $0.98 Beats $0.95 Estimate, Sales $9.964B Beat $9.880B Estimate

Author: Benzinga Newsdesk | April 17, 2024 07:32am
Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.95 by 3.16 percent. This is a 4.85 percent decrease over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $9.964 billion which beat the analyst consensus estimate of $9.880 billion by 0.85 percent. This is a 2.23 percent increase over sales of $9.747 billion the same period last year.

Posted In: ABT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist